PUBLISHER: The Business Research Company | PRODUCT CODE: 1948297
PUBLISHER: The Business Research Company | PRODUCT CODE: 1948297
Surgical hemostats are specialized tools or substances used during surgery to control bleeding by either clamping blood vessels or encouraging blood clot formation. Their purpose is to maintain a clear surgical area and minimize blood loss, improving visibility and safety throughout the procedure.
The primary types of surgical hemostats include topical thrombin-based hemostats, flowable hemostats, collagen-based hemostats, oxidized regenerated cellulose-based hemostats, gelatin-based hemostats, combination hemostats, and others. Topical thrombin-based hemostats are applied directly to bleeding areas to stimulate clotting by converting fibrinogen into fibrin through the action of thrombin. These come in various forms such as matrix and gel, sponges, sheets and pads, and powders. They are used in a wide range of surgeries including neurological, orthopedic, cardiovascular, gynecological, trauma, and plastic surgeries. These products are utilized by various end users including hospitals, ambulatory surgical centers, specialty clinics, and more.
Tariffs have influenced the surgical hemostats market by affecting the cost and availability of raw materials such as collagen, gelatin, and synthetic polymers used in hemostatic products. Increased tariffs have raised production costs, particularly for matrix and gel hemostats, flowable hemostats, and topical thrombin-based hemostats, impacting key regions like North America and Europe where imports are significant. While this has created challenges for manufacturers, it has also encouraged local production and sourcing strategies, potentially reducing dependency on imports and driving innovation in cost-effective hemostat solutions.
The surgical hemostats market research report is one of a series of new reports from The Business Research Company that provides surgical hemostats market statistics, including surgical hemostats industry global market size, regional shares, competitors with a surgical hemostats market share, detailed surgical hemostats market segments, market trends and opportunities, and any further data you may need to thrive in the surgical hemostats industry. This surgical hemostats market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The surgical hemostats market size has grown strongly in recent years. It will grow from $3.93 billion in 2025 to $4.2 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to rising surgical procedures, demand for blood loss management, advancement in surgical instruments, increase in hospital infrastructure, awareness about patient safety.
The surgical hemostats market size is expected to see strong growth in the next few years. It will grow to $5.41 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to innovation in hemostatic products, adoption of robotic-assisted surgeries, growth in outpatient surgical centers, integration of ai in healthcare, demand for biodegradable hemostats. Major trends in the forecast period include minimally invasive surgical techniques, advanced hemostatic materials development, point-of-care hemostasis monitoring, integration of ai in surgical planning, eco-friendly and sustainable surgical supplies.
The increasing number of trauma cases is expected to drive the growth of the surgical hemostats market in the near future. Trauma involves physical injury or emotional shock resulting from a distressing or harmful event, affecting an individual's body or mind. The rise in trauma cases is mainly due to a surge in road traffic accidents, which cause severe injuries needing immediate medical care. Surgical hemostats assist in quickly and effectively controlling bleeding during trauma cases, reducing blood loss and stabilizing patients for further treatment. For example, in 2023, the Wisconsin Department of Health Services reported that traumatic injuries caused by assault increased by 3% compared to 2022, rising from 1,544 cases to 1,584 cases. Hence, the growing occurrence of trauma cases is fueling the expansion of the surgical hemostats market.
Major companies operating in the surgical hemostat market are concentrating on creating advanced solutions, such as room-temperature-stable sealing patches, to improve bleeding control, optimize operating-room efficiency, and overcome challenges related to cold-chain storage. Room-temperature sealing patches are next-generation hemostatic pads designed to retain full functionality without the need for refrigeration, providing enhanced flexibility, quicker deployment, and better accessibility compared with conventional refrigerated or bulky sponge-based hemostats. For example, in May 2025, Baxter International Inc., a US-based healthcare company, launched the Hemopatch Sealing Hemostat RT, its newest collagen-based patch developed for effective hemostasis in both open and minimally invasive surgeries. The patch combines a biodegradable bovine-dermis collagen matrix with a thin NHS-PEG layer that forms a hydrogel upon fluid contact, enabling fast tissue adhesion and sealing while supporting natural platelet activity. Achieving hemostasis generally within approximately two minutes, offering biocompatibility, and fully resorbing within 6-8 weeks, the product also provides practical benefits such as room-temperature storage and an extended 36-month shelf life, enhancing surgical workflow and supply-chain flexibility.
In May 2025, Merit Medical Systems, Inc., a US-based medical device company, acquired Biolife Delaware for $120 million. Through this acquisition, Merit Medical Systems aims to broaden its hemostasis product portfolio and reinforce its position in the global market for rapid bleeding control solutions. BioLife Delaware, L.L.C. is a US-based medical device firm specializing in the development of surgical hemostatic products.
Major companies operating in the surgical hemostats market are Thermo Fisher Scientific Inc, Danaher Corporation, Agilent Technologies Inc, PerkinElmer Inc, Mettler Toledo International Inc, Shimadzu Corporation, Waters Corporation, Bruker Corporation, HORIBA Ltd, JEOL Ltd, Anton Paar GmbH, Renishaw plc, Metrohm AG, Genedata AG, HunterLab Europe GmbH, Avantes B V, JASCO Corporation, Wasatch Photonics Inc, Lablicate GmbH, StellarNet Inc, LabWare Inc, SciY Software GmbH
North America was the largest region in the surgical hemostats market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the surgical hemostats market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the surgical hemostats market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The surgical hemostats market consists of sales of mechanical hemostats, active hemostats, flowable hemostats, fibrin sealants, and combination hemostats. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Surgical Hemostats Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses surgical hemostats market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for surgical hemostats ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The surgical hemostats market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.